BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12166604)

  • 1. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
    Haffner SM
    Int J Clin Pract Suppl; 2002 Jul; (129):33-9. PubMed ID: 12166604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
    Liebl A
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?
    Scheen AJ
    Diabetes Metab; 2007 Feb; 33(1):3-12. PubMed ID: 17258489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing type II diabetes mellitus.
    Prisant LM
    J Clin Pharmacol; 2004 Apr; 44(4):406-13. PubMed ID: 15051749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention of type 2 diabetes: what is the evidence?
    Chiasson JL; Brindisi MC; Rabasa-Lhoret R
    Minerva Endocrinol; 2005 Sep; 30(3):179-91. PubMed ID: 16208307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.
    Tentolouris N; Boutati E; Karambakalis N; Perrea D; Tselepis AD; Tsoukala C; Kyriaki D; Lourida E; Anastasopoulou I; Karafoullidou A; Raptis SA; Katsilambros N
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):6-12. PubMed ID: 15871845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.
    Boutati EI; Raptis SA
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S13-23. PubMed ID: 15551342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.
    Ceriello A; Davidson J; Hanefeld M; Leiter L; Monnier L; Owens D; Tajima N; Tuomilehto J;
    Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):453-6. PubMed ID: 16934443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin for prevention of type 2 diabetes.
    Hess AM; Sullivan DL
    Ann Pharmacother; 2004; 38(7-8):1283-5. PubMed ID: 15150378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of tissue damage in the postprandial state.
    Ceriello A
    Int J Clin Pract Suppl; 2001 Sep; (123):7-12. PubMed ID: 11594300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
    Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
    Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
    Zeymer U
    Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of type 2 diabetes: are we ready?
    Bouche C; Goldfine AB
    Minerva Med; 2003 Feb; 94(1):9-18. PubMed ID: 12719698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmet needs in controlling metabolic disease.
    Haffner SM
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can type 2 diabetes mellitus be considered preventable?
    Jermendy G
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S73-81. PubMed ID: 15955380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet and exercise in the prevention of diabetes.
    Ryan DH;
    Int J Clin Pract Suppl; 2003 Mar; (134):28-35. PubMed ID: 12793595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.